ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 171,47
0,70%
Dow Jones
41 964,63
0,92%
DAX
23 288,06
-0,45%
Brent Oil
70,585
0,61%
Bitcoin
85 638,00
3,53%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) Actualités

COLL

Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:COLL
DateHeureSourceTitreSymboleSociété
19/03/202521h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
19/03/202521h34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
19/03/202500h18Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:COLLCollegium Pharmaceutical Inc
17/03/202512h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
17/03/202512h00GlobeNewswire Inc.Collegium Announces Updates to its Board of Directors and Executive Leadership TeamNASDAQ:COLLCollegium Pharmaceutical Inc
14/03/202521h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
10/03/202523h57GlobeNewswire Inc.Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health CareNASDAQ:COLLCollegium Pharmaceutical Inc
06/03/202522h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COLLCollegium Pharmaceutical Inc
04/03/202514h00GlobeNewswire Inc.Collegium to Participate in Upcoming Investor ConferencesNASDAQ:COLLCollegium Pharmaceutical Inc
27/02/202522h01GlobeNewswire Inc.Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
13/02/202522h01Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:COLLCollegium Pharmaceutical Inc
13/02/202514h00GlobeNewswire Inc.Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025NASDAQ:COLLCollegium Pharmaceutical Inc
05/02/202514h00GlobeNewswire Inc.Collegium Appoints Nancy S. Lurker to its Board of DirectorsNASDAQ:COLLCollegium Pharmaceutical Inc
08/01/202514h00GlobeNewswire Inc.Collegium Provides 2025 Financial Guidance and Business UpdateNASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422h02GlobeNewswire Inc.Collegium Reports Record Third Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
07/11/202422h01GlobeNewswire Inc.Collegium Appoints Vikram Karnani as Chief Executive OfficerNASDAQ:COLLCollegium Pharmaceutical Inc
24/10/202414h00GlobeNewswire Inc.Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
30/08/202414h00GlobeNewswire Inc.Collegium to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
28/08/202414h00GlobeNewswire Inc.Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024NASDAQ:COLLCollegium Pharmaceutical Inc
08/08/202422h01GlobeNewswire Inc.Collegium Reports Second Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
29/07/202412h00GlobeNewswire Inc.Collegium to Acquire Ironshore Therapeutics, Expanding into NeurologyNASDAQ:COLLCollegium Pharmaceutical Inc
25/07/202414h00GlobeNewswire Inc.Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
13/06/202414h00GlobeNewswire Inc.Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta FranchiseNASDAQ:COLLCollegium Pharmaceutical Inc
29/05/202417h19Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:COLLCollegium Pharmaceutical Inc
29/05/202414h00GlobeNewswire Inc.Collegium to Participate in Jefferies Global Healthcare ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
13/05/202414h00GlobeNewswire Inc.Collegium Announces $35 Million Accelerated Share Repurchase ProgramNASDAQ:COLLCollegium Pharmaceutical Inc
10/05/202414h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/202422h02GlobeNewswire Inc.Collegium Reports First Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/202422h01GlobeNewswire Inc.Collegium Announces CEO TransitionNASDAQ:COLLCollegium Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:COLL

Dernières Valeurs Consultées

TSXV
FUND
Katipult Technology
TG
T5W
Just Eat Takeaway.com N.V
FX
JPYIDR
Yen vs IDR
COIN
ADSGBP
AdShares
COIN
DHCUSD
DeltaHub Community
TSXV
M.DB
Myriad Uranium
NASDAQ
DFLIW
Dragonfly Energy
COIN
PTERIAUSD
Pteria
TSXV
ACAP.P
Atlas One Capital
NASDAQ
DWCH
TG
SBX
SynBiotic
TSXV
RAP.H
New Global Acreage Resou...
AMEX
EAGL
Eagle Capital Select Equ...
NASDAQ
DHC
Diversified Healthcare
NASDAQ
FACT
FACT II Acquisition
TSX
IVQ.DB.U
Invesque
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces